{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:08:58Z","timestamp":1779941338783,"version":"3.53.1"},"reference-count":36,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/or.2014.3634","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T17:08:02Z","timestamp":1417194482000},"page":"826-832","source":"Crossref","is-referenced-by-count":15,"title":["Combination therapy with \u03b1-galactosylceramide and a Toll-like receptor agonist exerts an augmented suppressive effect on lung tumor metastasis in a mouse model"],"prefix":"10.3892","volume":"33","author":[{"given":"TATSUYA","family":"ANDO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROYASU","family":"ITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUKO","family":"ARIOKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEYUKI","family":"OGISO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MITSURU","family":"SEISHIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,28]]},"reference":[{"key":"key20180107213316_b1-or-33-02-0826","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-12-1947","article-title":"Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-\u03b3 production","volume":"19","author":"Saga","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180107213316_b2-or-33-02-0826","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat Med"},{"key":"key20180107213316_b3-or-33-02-0826","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","article-title":"Toward an understanding of NKT cell biology: progress and paradoxes","volume":"23","author":"Kronenberg","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"key20180107213316_b4-or-33-02-0826","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri854","article-title":"The unconventional lifestyle of NKT cells","volume":"2","author":"Kronenberg","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"key20180107213316_b5-or-33-02-0826","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.21.120601.141057","article-title":"The regulatory role of V\u03b114 NKT cells in innate and acquired immune response","volume":"21","author":"Taniguchi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"key20180107213316_b6-or-33-02-0826","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.4049\/jimmunol.1103582","article-title":"Role of \u03b3\u03b4 T cells in \u03b1-galactosylceramide-mediated immunity","volume":"188","author":"Paget","year":"2012","journal-title":"J Immunol"},{"key":"key20180107213316_b7-or-33-02-0826","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/14712590802653601","article-title":"NKT cell immune responses to viral infection","volume":"13","author":"Tessmer","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107213316_b8-or-33-02-0826","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrmicro1657","article-title":"The unique role of natural killer T cells in the response to microorganisms","volume":"5","author":"Tupin","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"key20180107213316_b9-or-33-02-0826","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/156652409787314534","article-title":"Natural killer T cells and autoimmune disease","volume":"9","author":"Wu","year":"2009","journal-title":"Curr Mol Med"},{"key":"key20180107213316_b10-or-33-02-0826","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1158\/0008-5472.CAN-13-0875","article-title":"Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity","volume":"73","author":"Perret","year":"2013","journal-title":"Cancer Res"},{"key":"key20180107213316_b11-or-33-02-0826","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.4049\/jimmunol.176.8.4894","article-title":"TLR3 can directly trigger apoptosis in human cancer cells","volume":"176","author":"Salaun","year":"2006","journal-title":"J Immunol"},{"key":"key20180107213316_b12-or-33-02-0826","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1158\/1078-0432.CCR-10-3262","article-title":"Intratumoral administration of TLR4 agonist absorbed into a cellular vector improves antitumor responses","volume":"17","author":"Davis","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107213316_b13-or-33-02-0826","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.leu.2404456","article-title":"Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia","volume":"21","author":"Spaner","year":"2007","journal-title":"Leukemia"},{"key":"key20180107213316_b14-or-33-02-0826","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1172\/JCI63606","article-title":"Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans","volume":"122","author":"Ochi","year":"2012","journal-title":"J Clin Invest"},{"key":"key20180107213316_b15-or-33-02-0826","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/09680519050110040501","article-title":"Augmentation of lipopolysaccharide-induced nitric oxide production by \u03b1-galactosylceramide in mouse peritoneal cells","volume":"11","author":"Ito","year":"2005","journal-title":"J Endotoxin Res"},{"key":"key20180107213316_b16-or-33-02-0826","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/labinvest.3700388","article-title":"Lethal endotoxic shock using \u03b1-galactosylceramide sensitization as a new experimental model of septic shock","volume":"86","author":"Ito","year":"2006","journal-title":"Lab Invest"},{"key":"key20180107213316_b17-or-33-02-0826","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bbrc.2008.11.075","article-title":"V\u03b114 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes","volume":"378","author":"Ohtaki","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107213316_b18-or-33-02-0826","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/srep02559","article-title":"Toll-like receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes","volume":"3","author":"Ando","year":"2013","journal-title":"Sci Rep"},{"key":"key20180107213316_b19-or-33-02-0826","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/1521-4141(200106)31:6<1720::AID-IMMU1720>3.0.CO;2-U","article-title":"Critical contribution of IFN-\u03b3 and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of \u03b1-galactosylceramide","volume":"31","author":"Hayakawa","year":"2001","journal-title":"Eur J Immunol"},{"key":"key20180107213316_b20-or-33-02-0826","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ajog.2004.05.007","article-title":"Interferon-\u03b3 expression is an independent prognostic factor in ovarian cancer","volume":"191","author":"Marth","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107213316_b21-or-33-02-0826","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2220\/biomedres.32.159","article-title":"One-step simple assay to determine antigen-specific cytotoxic activities by single-color flow cytometry","volume":"32","author":"Nakagawa","year":"2011","journal-title":"Biomed Res"},{"key":"key20180107213316_b22-or-33-02-0826","doi-asserted-by":"crossref","first-page":"868345","DOI":"10.1155\/2011\/868345","article-title":"Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8+ CD122+ T cells","volume":"2011","author":"Seki","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"key20180107213316_b23-or-33-02-0826","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1440-1711.2000.00936.x","article-title":"Role of CD8+ T cells in mycobacterial infections","volume":"78","author":"Smith","year":"2000","journal-title":"Immunol Cell Biol"},{"key":"key20180107213316_b24-or-33-02-0826","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clim.2011.04.017","article-title":"Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects","volume":"140","author":"Exley","year":"2011","journal-title":"Clin Immunol"},{"key":"key20180107213316_b25-or-33-02-0826","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.4049\/jimmunol.181.4.2446","article-title":"IFN-\u03b3-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses","volume":"181","author":"Moreno","year":"2008","journal-title":"J Immunol"},{"key":"key20180107213316_b26-or-33-02-0826","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1158\/1535-7163.MCT-09-1198","article-title":"Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8","volume":"9","author":"Wang","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"key20180107213316_b27-or-33-02-0826","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00262-013-1506-7","article-title":"Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells","volume":"63","author":"Lim","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107213316_b28-or-33-02-0826","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1158\/0008-5472.CAN-11-1459","article-title":"Dendritic cell internalization of \u03b1-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses","volume":"71","author":"Choi","year":"2011","journal-title":"Cancer Res"},{"key":"key20180107213316_b29-or-33-02-0826","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20042592","article-title":"Sustained expansion of NKT cells and antigen-specific T cells after injection of \u03b1-galactosyl-ceramide loaded mature dendritic cells in cancer patients","volume":"201","author":"Chang","year":"2005","journal-title":"J Exp Med"},{"key":"key20180107213316_b30-or-33-02-0826","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.4049\/jimmunol.0803340","article-title":"IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer","volume":"182","author":"Andersson","year":"2009","journal-title":"J Immunol"},{"key":"key20180107213316_b31-or-33-02-0826","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1158\/0008-5472.CAN-12-4366","article-title":"IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment","volume":"73","author":"Wong","year":"2013","journal-title":"Cancer Res"},{"key":"key20180107213316_b32-or-33-02-0826","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00262-010-0901-6","article-title":"Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy","volume":"59","author":"Wang","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107213316_b33-or-33-02-0826","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2009-02-205492","article-title":"NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-\u03b3 and CXCR3 chemokines","volume":"114","author":"Wallace","year":"2009","journal-title":"Blood"},{"key":"key20180107213316_b34-or-33-02-0826","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2990.2010.01089.x","article-title":"Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum","volume":"36","author":"M\u00fcller","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key20180107213316_b35-or-33-02-0826","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.4049\/jimmunol.0903831","article-title":"CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors","volume":"184","author":"Rosenblum","year":"2010","journal-title":"J Immunol"},{"key":"key20180107213316_b36-or-33-02-0826","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1158\/0008-5472.CAN-09-2982","article-title":"Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy","volume":"70","author":"Takeshima","year":"2010","journal-title":"Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3634\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T22:31:25Z","timestamp":1566081085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,28]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,11,28]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/or.2014.3634"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3634","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,28]]}}}